-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
President and Director, Fred Hutchinson Cancer Research Center
-
Founder and CTO, Shopximity
-
Chair, Dept. of Cellular and Molecular Pharmacology, UCSF
-
Nobel Laureate, Professor of Biology, Caltech
-
Meet All the Xconomists ›
-
Chairman, CEO, Acucela
-
Co-Founder, Hunch and Founder Collective
-
CEO, TrustPlus
-
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3
|
Luke Timmerman |
05/23/12 |
Seattle
|
|
From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
|
Gregory T. Huang |
05/17/12 |
Boston
|
|
Bursting the Education Bubble: MIT and Harvard’s edX Is Just the Beginning
|
Gregory T. Huang |
05/02/12 |
Boston
|
|
Paul Allen Commits $300M to Expand Institute for Brain Science
|
Luke Timmerman |
03/21/12 |
Seattle
|
|
Zipcar and Fontinalis Bet $13.7M on Car-Sharing Startup Wheelz
|
Gregory T. Huang |
02/22/12 |
Boston
|
|
Scientists Morph Into Entrepreneurs Through NSF I-Corps Program
|
Wade Roush |
12/19/11 |
San Francisco
|
|
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO
|
Luke Timmerman |
12/14/11 |
San Diego
|
|
The Startup Team
|
Steve Blank |
12/13/11 |
San Francisco
|
|
Steve Jobs’s Dying Realization About Biology and Technology
|
Luke Timmerman |
12/05/11 |
National
|
|
7 Questions LPs Should Ask VCs (But Don’t)
|
Larry Chiang |
11/22/11 |
San Francisco
|
|
HackNY Connects Future Innovators to New York’s Startup Scene
|
João-Pierre S. Ruth |
11/09/11 |
New York
|
|
Celgene To Pump $45M into Quanticel to Discover Cancer Drugs, Gets Option To Acquire
|
Luke Timmerman |
11/04/11 |
San Francisco
|
|
Kaggle Secures $11,000,000 Series A Round
|
VentureDeal |
11/03/11 |
San Francisco
|
|
Five Things I Learned at Startup School
|
Larry Chiang |
10/26/11 |
San Francisco
|
|
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes
|
Luke Timmerman |
10/18/11 |
San Francisco
|
|
Mayor Bloomberg Announces New Advisory Council on Technology at NY Tech Meetup
|
João-Pierre S. Ruth |
10/13/11 |
New York
|
|
How Will Your Doctor Use Your Genome? Ask Our Panel Oct. 24
|
Luke Timmerman |
10/12/11 |
San Francisco
|
|
When Will Software for the Genome Take Off? Find out Oct. 24
|
Luke Timmerman |
10/07/11 |
San Francisco
|
|
Complete Genomics, PacBio CEOs to Lead Off “Computing in the Age of the $1K Genome” Oct. 24
|
Luke Timmerman |
09/27/11 |
San Francisco
|
|
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C
|
Luke Timmerman |
09/22/11 |
Seattle
|
|
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva
|
Luke Timmerman |
09/15/11 |
Seattle
|
|
Computing in the Age of the $1,000 Genome. Our Next Big Event in SF Oct. 24
|
Luke Timmerman |
09/14/11 |
San Francisco
|
|
RF Surgical Adds $12M to Make Sure Surgeons Don’t Leave Sponges Inside Patients
|
Luke Timmerman |
09/13/11 |
Seattle
|
|
RF Surgical Systems Obtains $12,000,000 New Funding
|
VentureDeal |
09/13/11 |
Seattle
|
|
Computing in the Age of the $1,000 Genome: Speakers from Wired, Fortune Join All-Star Lineup
|
Luke Timmerman |
08/30/11 |
San Francisco
|
|
Thane Kreiner, the Biotech-Entrepreneur-Turned-Educator With 1 Billion People on His Mind
|
Luke Timmerman |
08/25/11 |
San Francisco
|
|
BirchBox Secures $10,500,000 Series A Round
|
VentureDeal |
08/18/11 |
New York
|
|
Computing in the Age of the $1000 Genome: Xconomy to Convene Next Big SF Event Oct. 24
|
Luke Timmerman |
08/16/11 |
San Francisco
|
|
Highland Capital Announces 10 Startup Teams
|
Gregory T. Huang |
07/20/11 |
Boston
|
|
Acquia Scores $15M for Social Publishing
|
Gregory T. Huang |
07/20/11 |
Boston
|
|
Page 1 of
5 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.